Biologics Supplier for Orthopedic Practices in Springfield, MA

How orthopedic groups structure vendor qualification

Orthopedic practices and surgery centers typically formalize biologics sourcing before any physician places an order. A qualification step usually includes a review of the supplier's documentation set, confirmation that tissue is processed under an HCT/P framework, and a clear chain of custody from recovery to delivery.

Practices in this category also tend to centralize purchasing through a single administrator or medical director rather than individual providers, which simplifies lot tracking at the patient record level.

• Certificate of analysis for the specific lot
• Donor eligibility summary
• Lot release record
• Description of processing timelines and storage conditions

NPI-verified accounts

Precision Biologics opens accounts only after an NPI number is confirmed. This keeps ordering limited to licensed physicians and practices operating under physician supervision, and it lets each order tie back to a specific, verifiable provider record.

No product is sold directly to patients, and no clinical guidance, dosing, or procedural instruction is provided as part of account setup.

Receiving shipments in the Northeast

Cryopreserved products are recovered and processed within 48 hours, frozen using a slow-rate protocol, and stored at -80 degrees Celsius until shipment. Orders are shipped overnight on dry ice in validated containers, which means a Springfield practice should have a freezer-ready receiving process and a named staff member available to check the shipment in on arrival.

Because transit time affects a dry-ice shipment's margin for temperature control, practices in the region are encouraged to confirm delivery windows in advance rather than defaulting to standard business-hours scheduling.

Verifying regulatory standing before ordering

Decisions about whether a specific intended use of a Wharton's jelly or exosome product fits within applicable federal regulation belong to the practice and its own legal counsel, not the supplier. Massachusetts practices should also confirm scope-of-practice and supervision requirements directly with the Massachusetts medical board.

Precision Biologics supports this process with physician-level peer conversations about product documentation and makes registration and licensure records available to verified accounts, but does not advise on clinical use or interpret the regulation on a practice's behalf.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.